Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene

Conditions

• Dystrophic Epidermolysis Bullosa

Interventions

• DRUG: PTW-002 10 mg/g gel
• DRUG: Placebo

Sponsor

Phoenicis Therapeutics